HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review (2024)
- Authors:
- USP affiliated authors: AGUIAR, PATRICIA MELO - FCF ; BIGLIA, LUIZA VASCONCELOS - FCF
- Unidade: FCF
- DOI: 10.1016/j.healthpol.2024.105080
- Subjects: DOENÇAS RARAS; MEDICAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: Health Policy
- ISSN: 0168-8510
- Volume/Número/Paginação/Ano: v. 144, p. 1-8 art. 105080, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FELIPPINI, Arturo et al. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, v. 144, p. 1-8 art. 105080, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.healthpol.2024.105080. Acesso em: 17 fev. 2026. -
APA
Felippini, A., Biglia, L. V., Lima, T. de M., & Aguiar, P. M. (2024). HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review. Health Policy, 144, 1-8 art. 105080. doi:10.1016/j.healthpol.2024.105080 -
NLM
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2026 fev. 17 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080 -
Vancouver
Felippini A, Biglia LV, Lima T de M, Aguiar PM. HTA criteria adopted in different models of public healthcare systems for orphan drugs: a scoping review [Internet]. Health Policy. 2024 ; 144 1-8 art. 105080.[citado 2026 fev. 17 ] Available from: https://dx.doi.org/10.1016/j.healthpol.2024.105080 - Expert validation on proposed framework for differentiated HTA criteria for rare disease drugs in Brazil
- Desenvolvimento e validação de critérios diferenciados para Avaliação de Tecnologias em Saúde (ATS) de doenças raras no SUS
- Economic evaluations on the use of aripiprazole for patients with schizophrenia: a systematic review
- Prevalence of depression and anxiety among pharmacy students: a systematic review
- Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review
- Pharmacist interventions in schizophrenia and bipolar affective disorder: a systematic review and meta-analysis
- Use of medications by patients who are Deaf or Hard of Hearing: Reflections for the promotion of rational use
- Colaboração médico-farmacêutico no manejo de pacientes com diabetes mellitus tipo 2: expectativas e resultados
- Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil
- Pharmacist participated medication review in different practice settings: service or intervention? an overview of systematic reviews
Informações sobre o DOI: 10.1016/j.healthpol.2024.105080 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
